ML20236T826

From kanterella
Revision as of 23:27, 19 February 2021 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Expresses Appreciation for Visit to Observe Implementation of NRC Regulations Re Use of Radiopharms
ML20236T826
Person / Time
Issue date: 01/15/1987
From: Carr K
NRC COMMISSION (OCM)
To: Reba R
GEORGE WASHINGTON UNIV. MEDICAL CENTER, WASHINGTON
Shared Package
ML20235F951 List: ... further results
References
FRN-52FR36942, RULE-PR-35 AC65-1-048, AC65-1-48, NUDOCS 8712020117
Download: ML20236T826 (1)


Text

- . _ _ _ _

w

~

. ,eu

.8 C# - ( u t-]/)lfd G O S Y

,/* -

UNITED STATES g $

NUCLEAR REGULATORY COMMISSION WASHIN GTON, D.C. 20555

%..../ Ygf" I

co$ ssif January 15, 1987 Richard C. Reba, M.D.

Director, Division of Nuclear Medicine J George Washington University Medical Center 901 23rd Street, NW Washington, D.C. 20037

Dear Dr. Reba:

I enjoyed meeting with you and members of your staff during my recent visit to George Washington University Medical Center. Please convey my thanks to Dr. Cianci for his informative discussion of nuclear medicine techniques and use of radiopharmaceuticals in this process.

Our discussion and the opportunity to observe how NRC regulations are implemented will be most helpful to me.

Sincerely, 2::5k Kenneth M. Carr Commissioner

_ _ __